BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32373254)

  • 1. Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa.
    Richardson LC; Moss WJ
    Pan Afr Med J; 2020; 35(Suppl 1):3. PubMed ID: 32373254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunization Programme and Coverage against Measles and Rubella in Spain. Challenges for Achieving their Elimination].
    Limia Sánchez A; Molina Olivas M
    Rev Esp Salud Publica; 2015; 89(4):357-64. PubMed ID: 26580791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination.
    Prausnitz MR; Goodson JL; Rota PA; Orenstein WA
    Curr Opin Virol; 2020 Apr; 41():68-76. PubMed ID: 32622318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strengthening routine immunization through measles-rubella elimination.
    Biellik RJ; Orenstein WA
    Vaccine; 2018 Sep; 36(37):5645-5650. PubMed ID: 30041881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles-rubella mass immunization campaign in Albania, November 2000.
    Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
    J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
    Kriss JL; Grant GB; Moss WJ; Durrheim DN; Shefer A; Rota PA; Omer SB; Masresha BG; Mulders MN; Hanson M; Linkins RW; Goodson JL
    Vaccine; 2019 Sep; 37(38):5745-5753. PubMed ID: 30898393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of vaccination coverage of measles-rubella campaign in Imphal East District, Manipur: A cross-sectional study.
    Rajkumari B; Keisam A; Haobam DS; Thounaojam T
    Indian J Public Health; 2020; 64(2):173-177. PubMed ID: 32584301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles and rubella elimination in the Eastern Mediterranean Region: successes and challenges.
    Teleb N; Atta H; Hajjeh R
    East Mediterr Health J; 2019 Nov; 25(10):667-668. PubMed ID: 31774131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
    Newtonraj A; Vincent A; Selvaraj K; Manikandan M
    Rural Remote Health; 2019 Sep; 19(3):5261. PubMed ID: 31529972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques.
    Joyce JC; Carroll TD; Collins ML; Chen MH; Fritts L; Dutra JC; Rourke TL; Goodson JL; McChesney MB; Prausnitz MR; Rota PA
    J Infect Dis; 2018 Jun; 218(1):124-132. PubMed ID: 29701813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [National immunization program initiatives-What are their contribution to the elimination of measles and rubella in Germany?].
    Kouros B; Nennstiel U; Liebl B; Ludwig MS
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Apr; 62(4):386-391. PubMed ID: 30788537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovations in vaccine delivery: increasing access, coverage, and equity and lessons learnt from measles and rubella elimination.
    Goodson JL; Rota PA
    Drug Deliv Transl Res; 2022 May; 12(5):959-967. PubMed ID: 35211868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    Subaiya S; Tabu C; N'ganga J; Awes AA; Sergon K; Cosmas L; Styczynski A; Thuo S; Lebo E; Kaiser R; Perry R; Ademba P; Kretsinger K; Onuekwusi I; Gary H; Scobie HM
    PLoS One; 2018; 13(7):e0199786. PubMed ID: 29965975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activities to catch up and Vaccinate the Susceptible Population in Valencian Community, Spain].
    Martín-Ivorra R; Alguacil-Ramos AM; Lluch-Rodrigo JA; Pastor-Villalba E; Portero-Alonso A
    Rev Esp Salud Publica; 2015; 89(4):419-26. PubMed ID: 26580797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide campaign for vaccination of adults against rubella and measles--Costa Rica, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):976-9. PubMed ID: 11724151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel surveillance shows small decline in MMR coverage.
    Commun Dis Rep CDR Wkly; 1998 Sep; 8(36):317, 320. PubMed ID: 9782644
    [No Abstract]   [Full Text] [Related]  

  • 18. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrating Blood Collection within Household Surveys: Lessons Learned from Nesting a Measles and Rubella Serological Survey within a Post-Campaign Coverage Evaluation Survey in Southern Province, Zambia.
    Mutembo S; Carcelen A; Mwansa FD; Searle K; Wanyiri JW; Book C; Thuma PE; Moss WJ; Hayford K
    Am J Trop Med Hyg; 2018 Dec; 99(6):1639-1642. PubMed ID: 30277204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles and Rubella Global Strategic Plan 2012-2020 midterm review.
    Orenstein WA; Hinman A; Nkowane B; Olive JM; Reingold A
    Vaccine; 2018 Jan; 36 Suppl 1():A1-A34. PubMed ID: 29307367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.